Furthermore, CD4+ (Supplementary Figure S6C) as well as CD8+ (Supplementary Figure S6D) T cells showed an increased maturation stage (memory phenotype; gating strategy, Supplementary Figure S6A) in tumor-free HTM, suggesting an effective T cell defense against low tumor cell count transplantation. This evidence concerns the gene CD8A and neoplasm.